Literature DB >> 11940589

Serial triggering of T cell receptors results in incremental accumulation of signaling intermediates.

Zipora Borovsky1, Galit Mishan-Eisenberg, Einat Yaniv, Jacob Rachmilewitz.   

Abstract

Triggering of the T cell receptor (TCR) leads to the production of intracellular intermediates with half-life of a few minutes. Signaling kinetics of events originating from serial TCR triggering and its relation to antigen dose was investigated. In this study we documented incremental accumulation of short-lived intermediates of the extracellular signal-regulated kinase (ERK) family, produced during successive TCR triggering. The rate and extent of the intermediate accumulation are essentially determined by the level of TCR engagement and are augmented by costimulation. ERK-1 and ERK-2 exhibit different rates of accumulation following serial receptor triggering. The data indicate that the quantitative kinetic differences in downstream signaling pathways induce qualitatively distinct biological outcomes. Although CD69, interleukin-2, and interferon-gamma (IFN-gamma) were primarily produced by high antigen doses that supported high MAPK phosphorylation, maximal interleukin-5 expression is induced by low and intermediate stimulus doses that do not support significant accumulation of activated ERK. We further demonstrated that the rate of phosphorylated ERK accumulation correlates with the duration of delay between T cell stimulation and the onset of IFN-gamma response, with stronger stimuli giving a more rapid IFN-gamma response. This delay might reflect the time required for the accumulation of signaling intermediates up to a threshold level that is necessary for activation. Thus, the data suggest that signaling events originating from serially triggered TCR are not simply sustained but are gradually accumulated and are integrated in a corresponding response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940589     DOI: 10.1074/jbc.M201613200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

Review 2.  Development of thymically derived natural regulatory T cells.

Authors:  Matthew L Bettini; Dario A A Vignali
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 3.  T cell responses to antigen: hasty proposals resolved through long engagements.

Authors:  Karen Tkach; Grégoire Altan-Bonnet
Journal:  Curr Opin Immunol       Date:  2012-12-28       Impact factor: 7.486

4.  The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge.

Authors:  Leandro J Carreño; Susan M Bueno; Paulina Bull; Stanley G Nathenson; Alexis M Kalergis
Journal:  Immunology       Date:  2007-02-20       Impact factor: 7.397

Review 5.  Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.

Authors:  Michael C Jensen; Stanley R Riddell
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

6.  Commitment point during G0-->G1 that controls entry into the cell cycle.

Authors:  Nicholas C Lea; Stephen J Orr; Kai Stoeber; Gareth H Williams; Eric W-F Lam; Mohammad A A Ibrahim; Ghulam J Mufti; N Shaun B Thomas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14.

Authors:  Zohar Ochanuna; Anat Geiger-Maor; Adi Dembinsky-Vaknin; Dimitrios Karussis; Mark L Tykocinski; Jacob Rachmilewitz
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

8.  Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.

Authors:  Andrew E Schade; Gary L Schieven; Robert Townsend; Anna M Jankowska; Vojkan Susulic; Rosemary Zhang; Hadrian Szpurka; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2007-10-25       Impact factor: 22.113

9.  Kinetics and mechanics of two-dimensional interactions between T cell receptors and different activating ligands.

Authors:  Philippe Robert; Milos Aleksic; Omer Dushek; Vincenzo Cerundolo; Pierre Bongrand; P Anton van der Merwe
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

10.  Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.

Authors:  Omer Dushek; Milos Aleksic; Richard J Wheeler; Hao Zhang; Shaun-Paul Cordoba; Yan-Chun Peng; Ji-Li Chen; Vincenzo Cerundolo; Tao Dong; Daniel Coombs; P Anton van der Merwe
Journal:  Sci Signal       Date:  2011-06-07       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.